As a whole, our results suggested that some traditional prognostic factors, such as age at diagnosis, primary tumor size, lymph node status, AJCC stage III, HR status, Her2/neu status, histologic grade III, and LVI were ascribed to adverse prognostic factors for DFS and OS, regardless of breast cancer subtypes. Here, ERBB2 is linked to breast cancer.